Design of a prodrug bispecific antibody masked by a functional molecule for lymphocyte activation for cancer therapy
Although T cells engaging bispecific antibodies (T-bsAbs) have shown great benefits, their use in treating solid tumors is challenging because of the minimal infiltration of T-cells. We fused an agonistic sing...